Wong DT - Search Results

1

Bymaster F, Perry KW, Nelson DL, Wong DT, Rasmussen K, Moore NA, Calligaro DO. Bymaster F, et al. Among authors: wong dt. Br J Psychiatry Suppl. 1999;(37):36-40. Br J Psychiatry Suppl. 1999. PMID: 10211140 Review.

2

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, Seeman P, Wong DT. Bymaster FP, et al. Among authors: wong dt. Neuropsychopharmacology. 1996 Feb;14(2):87-96. doi: 10.1016/0893-133X(94)00129-N. Neuropsychopharmacology. 1996. PMID: 8822531

3

In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug.

Bymaster FP, Rasmussen K, Calligaro DO, Nelson DL, DeLapp NW, Wong DT, Moore NA. Bymaster FP, et al. Among authors: wong dt. J Clin Psychiatry. 1997;58 Suppl 10:28-36. J Clin Psychiatry. 1997. PMID: 9265914 Review.

4

Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum.

Li XM, Perry KW, Wong DT, Bymaster FP. Li XM, et al. Among authors: wong dt. Psychopharmacology (Berl). 1998 Mar;136(2):153-61. doi: 10.1007/s002130050551. Psychopharmacology (Berl). 1998. PMID: 9551772

5

Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex.

Zhang W, Perry KW, Wong DT, Potts BD, Bao J, Tollefson GD, Bymaster FP. Zhang W, et al. Among authors: wong dt. Neuropsychopharmacology. 2000 Sep;23(3):250-62. doi: 10.1016/S0893-133X(00)00119-6. Neuropsychopharmacology. 2000. PMID: 10942849

6

Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats.

Li SX, Perry KW, Wong DT. Li SX, et al. Among authors: wong dt. Neuropharmacology. 2002 Feb;42(2):181-90. doi: 10.1016/s0028-3908(01)00160-5. Neuropharmacology. 2002. PMID: 11804614

7

Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex.

Bymaster FP, Zhang W, Carter PA, Shaw J, Chernet E, Phebus L, Wong DT, Perry KW. Bymaster FP, et al. Among authors: wong dt. Psychopharmacology (Berl). 2002 Apr;160(4):353-61. doi: 10.1007/s00213-001-0986-x. Epub 2002 Jan 29. Psychopharmacology (Berl). 2002. PMID: 11919662

8

LY227942, an inhibitor of serotonin and norepinephrine uptake: biochemical pharmacology of a potential antidepressant drug.

Wong DT, Robertson DW, Bymaster FP, Krushinski JH, Reid LR. Wong DT, et al. Life Sci. 1988;43(24):2049-57. doi: 10.1016/0024-3205(88)90579-6. Life Sci. 1988. PMID: 2850421

9

Simultaneous increases of extracellular monoamines in microdialysates from hypothalamus of conscious rats by duloxetine, a dual serotonin and norepinephrine uptake inhibitor.

Engleman EA, Perry KW, Mayle DA, Wong DT. Engleman EA, et al. Among authors: wong dt. Neuropsychopharmacology. 1995 Jul;12(4):287-95. doi: 10.1016/0893-133X(94)00093-F. Neuropsychopharmacology. 1995. PMID: 7576005

10

Development of antidepressant drugs. Fluoxetine (Prozac) and other selective serotonin uptake inhibitors.

Wong DT, Bymaster FP. Wong DT, et al. Adv Exp Med Biol. 1995;363:77-95. Adv Exp Med Biol. 1995. PMID: 7618533 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

841 results

Search Page